615568-23-5

Basic information

• Product Name: 2H,3H-[1,4]dioxino[2,3-b]pyridin-6-ylMethanol
• Synonyms: 2H,3H-[1,4]dioxino[2,3-b]pyridin-6-ylMethanol
• CAS NO: 615568-23-5
• Molecular Formula: C8H9NO3
• Molecular Weight: 167.16196
• Mol File: 615568-23-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2H,3H-[1,4]dioxino[2,3-b]pyridin-6-ylMethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2H,3H-[1,4]dioxino[2,3-b]pyridin-6-ylMethanol(615568-23-5)
• EPA Substance Registry System: 2H,3H-[1,4]dioxino[2,3-b]pyridin-6-ylMethanol(615568-23-5)

Safety Data

• Hazardous Substances Data: 615568-23-5(Hazardous Substances Data)

Usage

General Description

2H,3H-[1,4]dioxino[2,3-b]pyridin-6-ylMethanol is a chemical compound with the molecular formula C10H9NO3. It is a derivative of pyridine and contains a dioxane ring fused to the pyridine ring. 2H,3H-[1,4]dioxino[2,3-b]pyridin-6-ylMethanol is commonly used in organic chemistry as a reagent for various reactions and as a building block for the synthesis of more complex molecules. It has potential applications in pharmaceutical and agrochemical industries due to its unique structure and properties. It is important to handle this compound with care as it is a potentially hazardous chemical and should only be used by trained professionals in a controlled laboratory setting.

Upstream product

• 443955-66-6 2-(2-iodo-6-methylpyridin-3-yloxy)ethanol 
• 129421-33-6 6-methyl-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine 
• 615568-21-3 6-methyl-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine 5-oxide 
• 1121-78-4 5-Hydroxy-2-methylpyridine 
• 23003-30-7 2-iodo-6-methyl-3-pyridinol 
• 1334784-91-6 acetic acid 2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethyl ester 

Downstream Products

• 615568-24-6 2,3-dihydro-[1,4]-dioxino[2,3-b]pyridine-6-carbaldehyde 
• 1334784-92-7 2-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)acetic acid 

Relevant articles and documents

DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF

The present invention relates to a group of 1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one (piperlongumine) derivatives, analogs and pharmaceutically acceptable salts thereof. The present invention also relates to a pharmaceutical composition and formulation containing a derivative of piperlongumine; and use of the derivatives and analogs for treating cancer, reducing inflammation and/or treating an autoimmune or inflammatory disease.

2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.5] NONANE DERIVATIVES

The present invention provides a compound of Formula (I) or a pharmaceutically salt thereof wherein R1, R2, Ra, L, Z, Z1 and Z2 are as defined herein, that act as Ghrelin antagonists or inverse agonists; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by the antagonism of the Ghrelin receptor.

NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS

Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives hereof useful in methods of treatment of bacterial infections in mammals, particularly man.